On the structure of endogenous ouabain.
1Department of Chemistry, Columbia University, New York, NY 10027, USA.
Summary
Researchers identified "endogenous ouabain," a sodium pump inhibitor, as ouabain due to borate complexation. This finding clarifies previous structural ambiguities and suggests ouabain may form complexes in vivo.
Area of Science:
- Biochemistry
- Pharmacology
- Structural Biology
Background:
- The mammalian sodium pump inhibitor, termed "endogenous ouabain," was thought to be a structural isomer of ouabain.
- Previous structural investigations were limited by insufficient sample quantities.
- The precise chemical identity and in vivo form of endogenous ouabain remained unclear.
Purpose of the Study:
- To elucidate the precise chemical structure of endogenous ouabain.
- To resolve discrepancies in previous structural analyses of this endogenous compound.
- To investigate the potential for complex formation of ouabain in biological systems.
Main Methods:
- Purification of endogenous ouabain from bovine hypothalamus (3 micrograms).
- 1H-NMR spectroscopy for structural characterization.
- Re-examination of historical microscale structural data.
- Analysis of potential complexation with borate ions.
Main Results:
- The purified endogenous ouabain was identified as ouabain, not a distinct isomer.
- Structural analysis was complicated by facile complexation of ouabain with borate in borosilicate glassware.
- The polyhydroxylated ouabain molecule can act as a polydentate ligand for inorganic species.
Conclusions:
- The perceived structural differences were artifacts of borate complexation during analysis.
- Endogenous ouabain is likely ouabain itself, with its structure influenced by complexation.
- The true chemical species responsible for hypothalamic inhibitory factor activity requires further clarification, considering potential in vivo complexation.
More Related Videos
07:16Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
08:49Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
Published on: June 20, 2025
Related Concept Videos
01:48ATP Synthase: Mechanism
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased ATP...
01:18ATP Synthase: Structure
ATP synthase or ATPase is among the most conserved proteins found in bacteria, mammals, and plants. This enzyme can catalyze a forward reaction in response to the electrochemical gradient, producing ATP from ADP and inorganic phosphate. ATP synthase can also work in a reverse direction by hydrolyzing ATP and generating an electrochemical gradient. Different forms of ATP synthases have evolved special features to meet the specific demands of the cell. Based on their specific feature, ATP...
01:29Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
00:59Structures of the Endocrine System
The intricate framework of the endocrine system encompasses a diverse array of glands, with their target tissues and organs strategically distributed throughout the body. Central to this network are the endocrine glands, specialized structures that lack ducts and release hormones directly into the interstitial fluid. Notably, the hypothalamus, a vital neuroendocrine organ situated in the brain, governs neural functions and serves as a potent source of hormonal regulation. Near the hypothalamus...
01:28Mechanism of Cardiac Arrhythmias
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
01:22Opioid Receptors: Overview
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...